Skip to main content

Table 4 Effect of simvastatin in CHD patients with MMP-9 rs3918242 polymorphism

From: Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease

 

week

CC (n = 188)

CT (n = 69)

TT (n = 7)

Mean ± SD

% Change

Mean ± SD

% Change

Mean ± SD

% Change

TG (mmol/L)

0

1.52 ± 0.19

28.13 ± 3.

1.73 ± 0.25

28.19 ± 3.0

1.87 ± 0.27*

28.12 ± 3.22

12

1.11 ± 0.21

29

1.21 ± 0.18

7

1.39 ± 0.23

 

TC (mmol/L)

0

5.15 ± 0.61

18.24 ± 2.

5.11 ± 0.59

18.59 ± 3.0

5.12 ± 0.51

18.71 ± 3.26

12

4.34 ± 0.47

67

4.36 ± 0.49

6

4.37 ± 0.56

 

HDL-C (mmol/L)

0

1.10 ± 0.19

15.23 ± 2.

1.09 ± 0.18

14.87 ± 2.6

1.13 ± 0.21

15.61 ± 2.42

12

1.29 ± 0.23

54

1.29 ± 0.22

1

1.29 ± 0.22

LDL-C (mmol/L)

0

3.09 ± 0.26

24.23 ± 5.

3.13 ± 0.28

27.50 ± 4.4

3.38 ± 0.37*

34.53 ± 4.0

12

2.35 ± 0.32

78

2.27 ± 0.24

4

2.10 ± 0.26*

0*

VLDL-C (mmol/L)

0

1.04 ± 0.16

34.16 ± 4.

1.01 ± 0.19

34.89 ± 4.5

1.08 ± 0.23

35.14 ± 4.6

12

0.79 ± 0.09

31

0.75 ± 0.11

7

0.81 ± 0.13

9

MMP-9 (ng/ml)

0

76.28 ± 21.26

24.38 ± 6.59

82.28 ± 21.26

23.10 ± 9.27

88.28 ± 22.47

22.37 ± 7.82

12

58.75 ± 20.21

 

63.75 ± 20.21

 

68.75 ± 20.21

 

TNF-α (pg/ml)

0

134.73 ± 51.38

26.48 ± 4.11

137.08 ± 55.63

25.07 ± 5.12

135.98 ± 60.12

24.46 ± 2.99

12

100.26 ± 49.34

 

106.65 ± 50.04

 

99.65 ± 43.87

 

IL-10 (pg/ml)

0

100.13 ± 36.17

47.33 ± 9.28

95.08 ± 34.79

52.04 ± 11.62

103.35 ± 40.14

48.27 ± 10.56

12

51.28 ± 26.21

 

47.29 ± 29.06

 

53.91 ± 22.38

 
  1. Values are expressed as mean ± SD. *P <0.0001 compared with the CC genotype by one-way ANOVA followed with Bonferroni post-hoc test for pair-wise comparison. § P <0.0001 compared with before treatment by paired student’s t-Test. HD coronary heart disease, MMP-9 matrix metalloproteinase-9, TC total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, VLDL-C very low density lipoprotein cholesterol